Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTHAR Gel for Resistant Nephrotic Syndrome
NCT01129284Phase 4Completed
- Sponsor
- Columbia University
- Start
- Dec 2009
- Primary completion
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in nephrotic syndrome, sponsored by Columbia University. Started Dec 2009; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT01129284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01129284.